September 2001 - Health Sciences Institute - Official Site

Are we raising a generation of addicts?

Do you remember the following commercial that ran on TV a few years ago? It showed a series of kids talking about what they wanted to be when they grew up: a teacher, an astronaut, a fire fighter.

Read more...

Study reveals weight poses greater health risk than smoking

There's so much pressure around us to be thin that it's easy to forget that optimal body weight really is about our health, and not just our pant size. But this week, a couple of new studies on health and weight confirmed that maintaining a healthy body weight is one of the most important things we can do for ourselves – and that letting it slide can be the most dangerous.

Read more...

New research that every woman should know about

Scientists in the Netherlands found significant evidence that both birth control pills and hormone replacement therapy increase a woman's risk of developing a condition called microalbuminuria. People with this condition have increased levels of protein in their urine, which is an early marker for kidney disease. And a Canadian study published in JAMA this past July concluded that microalbuminaria was a risk factor for heart disease, based on its analysis of more than 9,000 people age 55 and older.

Read more...

The soy controversy: More questions than answers

Ten days ago, we sent you a message on new research that was raising concerns about the safety of soy. Since then, many of you have written back to us to ask how you should alter your diet, or to point out apparent contradictions in the soy research.

Read more...

Research shows health risks of soy likely outweight benefits

Because I eat a lot of soy, I've been following the growing controversy about its safety. A majority of us, after all, are not at risk for kidney stones. But there is evidence that soy may contribute to vascular dementia, breast cancer, interference in thyroid function, osteoporosis, and other serious and potentially deadly diseases.

Read more...

Search for cancer killer leads researchers back to nature

Less than three years after testing the first dose on a human (half the normal testing time for a cancer drug), Novartis Pharmaceuticals presented GleevecTM to the FDA for approval. After a short two-and-a-half month review, FDA officials granted the New Drug Application in May. Twenty-four hours after that, trucks loaded with Gleevec pulled out of Novartis's warehouse in East Hanover, New Jersey. Novartis boasts that Gleevec enjoyed the fastest time to market of any cancer treatment in American history.

Read more...

Is the media swimming around the real threat to your health?

So far this summer, there have been 41 shark attacks in the U.S. from which 3 people died. Yet, 31 people have died in the U.S. taking the statin drug Baycol – 10 times more than have died in these shark attacks.

Read more...